School-Based trauma therapy shows promise for easing PTSD in kids
NCT ID NCT04451161
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested whether Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) can reduce PTSD and depression symptoms in children aged 8 to 19 when delivered in schools. It also tested a strategy to help school clinicians adopt and stick with the therapy. The trial involved 292 participants and measured symptom changes over two years.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Trauma-Focused Cognitive-Behavioral Therapy (TF-CBT) and a clinician support strategy (BASIS)
What this could lead to
If successful, this could make evidence-based trauma therapy more widely available in schools, helping more children recover from trauma.
What could go wrong
This is a completed implementation study, not a large-scale efficacy trial. Results may not apply to all schools or students, and the therapy's success depends on clinician training and adherence.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POST TRAUMATIC STRESS DISORDER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Washington
Seattle, Washington, 98115, United States